Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression

Fig. 1

SLC2A1-AS1 overexpression is correlated with TNM stage, lymph node metastasis and poor prognosis in ESCC patients. A. StarBase online software assay for SLC2A1-AS1 expression level in 162 cases of ESCA tissues and 11 normal samples. B. TCGA database assay for SLC2A1-AS1 expression level in EAC samples and normal samples. C. TCGA database investigation for SLC2A1-AS1 expression level in ESCC samples and normal samples. D. GEO dataset GSE111011 analysis for SLC2A1-AS1 expression level in 7 cases of ESCC tissues and paired normal tissues. E. qRT-PCR assay for SLC2A1-AS1 expression level in 60 cases of ESCC tissues and corresponding normal tissues. F. Representative images of FISH results regarding the high expression of SLC2A1-AS1 in ESCC tissues. G. The expression of SLC2A1-AS1 was detected by qRT-PCR in a panel of ESCC cells. H. The correlations between SLC2A1-AS1 expression level and clinicopathological features, including gender, sex, smoking, drinking, differentiation degree, tumor size, TNM stage and lymph node metastasis. I. Log-rank test determination for the prognostic value of SLC2A1-AS1 in ESCC patients. Compared to normal tissues or Het-1A cell, *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001, indicating statistical significance

Back to article page